GL Pharma was formed out of a merger of the two pharmaceutical companies Gerot and Lannacher and has a history of more than 70 years.
We develop, produce and market unique brand name products as well as off-patent products for the wellbeing of people in Austria and abroad. As a supplier to the healthcare sector, we partner with general practitioners, pharmacists, their patients and pharmaceutical wholesalers. As an international player, we market our products through our licensees and branch offices in more than 50 countries.
Our core competence concentrates on three different business areas:
Our products can be found in more than 50 markets worldwide. GL Pharma has 16 distribution structures in Europe and a subsidiary in Central America.
247 MEUR (2022), 363 MEUR group revenue including Genericon Pharma
Around 4.670 M defined daily doses
In healthcare, trust is required.
GL Pharma works closely with physicians, other healthcare professionals and medical facilities to provide an optimum patient care.
As a responsible company, GL Pharma is committed to transparency.
Within the EFPIA Transparency Code, we disclose financial contributions to healthcare professionals.